OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
5,594,400
Share change
-1,174,400
Total reported value
$27,460,661
Put/Call ratio
53%
Price per share
$4.91
Number of holders
62
Value change
-$5,776,081
Number of buys
30
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q4 2016

As of 31 Dec 2016, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,594,400 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Fund Advisors, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC, DEUTSCHE BANK AG\, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 62 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.